CN102613296A - 一种具有降糖降脂作用的奶茶 - Google Patents
一种具有降糖降脂作用的奶茶 Download PDFInfo
- Publication number
- CN102613296A CN102613296A CN2012101073528A CN201210107352A CN102613296A CN 102613296 A CN102613296 A CN 102613296A CN 2012101073528 A CN2012101073528 A CN 2012101073528A CN 201210107352 A CN201210107352 A CN 201210107352A CN 102613296 A CN102613296 A CN 102613296A
- Authority
- CN
- China
- Prior art keywords
- arabinose
- xylo
- oligosaccharide
- milk tea
- tea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001122767 Theaceae Species 0.000 title claims abstract description 192
- 235000000346 sugar Nutrition 0.000 title abstract description 19
- 239000008280 blood Substances 0.000 title abstract description 14
- 210000004369 blood Anatomy 0.000 title abstract description 14
- 235000013336 milk Nutrition 0.000 claims abstract description 190
- 239000008267 milk Substances 0.000 claims abstract description 190
- 210000004080 milk Anatomy 0.000 claims abstract description 190
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 165
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 claims abstract description 151
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims abstract description 150
- 230000000694 effects Effects 0.000 claims abstract description 74
- 239000000843 powder Substances 0.000 claims abstract description 31
- 230000002218 hypoglycaemic effect Effects 0.000 claims description 14
- 230000002401 inhibitory effect Effects 0.000 abstract description 76
- 230000005764 inhibitory process Effects 0.000 abstract description 45
- 102100024295 Maltase-glucoamylase Human genes 0.000 abstract description 41
- 108010028144 alpha-Glucosidases Proteins 0.000 abstract description 41
- -1 cholesteryl ester Chemical class 0.000 abstract description 23
- 230000006870 function Effects 0.000 abstract description 5
- 235000019626 lipase activity Nutrition 0.000 abstract description 5
- 239000008395 clarifying agent Substances 0.000 abstract 1
- 239000013049 sediment Substances 0.000 abstract 1
- 235000013616 tea Nutrition 0.000 description 177
- 108010055297 Sterol Esterase Proteins 0.000 description 35
- 102000000019 Sterol Esterase Human genes 0.000 description 35
- 108090001060 Lipase Proteins 0.000 description 32
- 239000004367 Lipase Substances 0.000 description 32
- 102000004882 Lipase Human genes 0.000 description 32
- 229940040461 lipase Drugs 0.000 description 32
- 235000019421 lipase Nutrition 0.000 description 32
- 239000000203 mixture Substances 0.000 description 32
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 24
- 230000002255 enzymatic effect Effects 0.000 description 20
- 102000019280 Pancreatic lipases Human genes 0.000 description 18
- 108050006759 Pancreatic lipases Proteins 0.000 description 18
- 238000002474 experimental method Methods 0.000 description 18
- 229940116369 pancreatic lipase Drugs 0.000 description 18
- 229930006000 Sucrose Natural products 0.000 description 17
- 239000005720 sucrose Substances 0.000 description 17
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 14
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 14
- 239000003112 inhibitor Substances 0.000 description 14
- 102000004190 Enzymes Human genes 0.000 description 13
- 108090000790 Enzymes Proteins 0.000 description 13
- 229940088598 enzyme Drugs 0.000 description 13
- 235000012000 cholesterol Nutrition 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 9
- 238000001556 precipitation Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000000523 sample Substances 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000004372 Polyvinyl alcohol Substances 0.000 description 5
- 230000008021 deposition Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 108010089254 Cholesterol oxidase Proteins 0.000 description 4
- 102000003992 Peroxidases Human genes 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 108040007629 peroxidase activity proteins Proteins 0.000 description 4
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000004448 titration Methods 0.000 description 4
- 150000003626 triacylglycerols Chemical class 0.000 description 4
- 241000186000 Bifidobacterium Species 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000032050 esterification Effects 0.000 description 3
- 238000005886 esterification reaction Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 239000012224 working solution Substances 0.000 description 3
- XUGISPSHIFXEHZ-UHFFFAOYSA-N 3beta-acetoxy-cholest-5-ene Natural products C1C=C2CC(OC(C)=O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 XUGISPSHIFXEHZ-UHFFFAOYSA-N 0.000 description 2
- YEYCQJVCAMFWCO-UHFFFAOYSA-N 3beta-cholesteryl formate Natural products C1C=C2CC(OC=O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 YEYCQJVCAMFWCO-UHFFFAOYSA-N 0.000 description 2
- 108010004103 Chylomicrons Proteins 0.000 description 2
- 150000000992 L-arabinoses Chemical class 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- CDVZCUKHEYPEQS-AZIZVCISSA-N (2r,3s,4s)-2,3,4,5-tetrahydroxypentanal Chemical compound OC[C@H](O)[C@H](O)[C@@H](O)C=O.OC[C@H](O)[C@H](O)[C@@H](O)C=O CDVZCUKHEYPEQS-AZIZVCISSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 108010071619 Apolipoproteins Proteins 0.000 description 1
- 102000007592 Apolipoproteins Human genes 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 241000218633 Pinidae Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 description 1
- 230000001315 anti-hyperlipaemic effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000012490 blank solution Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000006025 fining agent Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 239000003262 industrial enzyme Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 238000005360 mashing Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000000837 restrainer Substances 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000185 sucrose group Chemical group 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 229960003487 xylose Drugs 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
实施例 | 溶液中L-阿拉伯糖浓度(g/L) | α-葡萄糖苷酶活性抑制率(%) |
1 | 0.075 | 42.7 |
2 | 0.375 | 77.5 |
3 | 0.75 | 80.2 |
实施例 | L-阿拉伯糖(g/L) | 胆固醇酯酶活性抑制率(%) |
10 | 0.08 | 1.07 |
11 | 0.5 | 5.03 |
12 | 1 | 10.11 |
13 | 3 | 10.61 |
实施例 | L-阿拉伯糖(g/L) | 胰脂肪酶活性抑制率(%) |
22 | 0.25 | 5.3 |
23 | 0.5 | 11.91 |
24 | 1 | 11.98 |
25 | 20 | 12.13 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101073528A CN102613296A (zh) | 2012-03-05 | 2012-04-13 | 一种具有降糖降脂作用的奶茶 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210054377 | 2012-03-05 | ||
CN201210054377.6 | 2012-03-05 | ||
CN2012101073528A CN102613296A (zh) | 2012-03-05 | 2012-04-13 | 一种具有降糖降脂作用的奶茶 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102613296A true CN102613296A (zh) | 2012-08-01 |
Family
ID=46553775
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012101073528A Pending CN102613296A (zh) | 2012-03-05 | 2012-04-13 | 一种具有降糖降脂作用的奶茶 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102613296A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106689417A (zh) * | 2016-08-29 | 2017-05-24 | 合肥康桥工贸有限公司 | 一种控糖中老年高钙奶粉 |
CN107114507A (zh) * | 2017-03-27 | 2017-09-01 | 柳州市雨滴餐饮管理有限公司 | 一种具有益生元组合物奶茶及其制备方法 |
CN113796442A (zh) * | 2021-09-24 | 2021-12-17 | 南通银琪生物科技有限公司 | 一种健康咖啡粉的配方及制作工艺 |
CN113796443A (zh) * | 2021-09-24 | 2021-12-17 | 南通银琪生物科技有限公司 | 一种咖啡饮片的配方及制作工艺 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1067557A (zh) * | 1991-06-08 | 1993-01-06 | 周南吾 | 速溶奶茶的配制 |
CN1113687A (zh) * | 1994-06-01 | 1995-12-27 | 夏睦友 | 液体奶茶及制备方法 |
CN101011128A (zh) * | 2007-02-02 | 2007-08-08 | 郑长芳 | 一种豆奶茶粉及其制备方法 |
CN101810263A (zh) * | 2009-12-16 | 2010-08-25 | 上海和兴源生物科技有限公司 | 复合生物糖 |
CN101919459A (zh) * | 2009-06-11 | 2010-12-22 | 天津市恒安食品有限公司 | 奶茶浓缩饮料及其制作方法 |
CN101990945A (zh) * | 2009-08-21 | 2011-03-30 | 南通市百味食品有限公司 | 原味奶茶及其加工工艺 |
CN102058000A (zh) * | 2009-11-17 | 2011-05-18 | 天津天士力制药股份有限公司 | 一种速溶奶茶 |
-
2012
- 2012-04-13 CN CN2012101073528A patent/CN102613296A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1067557A (zh) * | 1991-06-08 | 1993-01-06 | 周南吾 | 速溶奶茶的配制 |
CN1113687A (zh) * | 1994-06-01 | 1995-12-27 | 夏睦友 | 液体奶茶及制备方法 |
CN101011128A (zh) * | 2007-02-02 | 2007-08-08 | 郑长芳 | 一种豆奶茶粉及其制备方法 |
CN101919459A (zh) * | 2009-06-11 | 2010-12-22 | 天津市恒安食品有限公司 | 奶茶浓缩饮料及其制作方法 |
CN101990945A (zh) * | 2009-08-21 | 2011-03-30 | 南通市百味食品有限公司 | 原味奶茶及其加工工艺 |
CN102058000A (zh) * | 2009-11-17 | 2011-05-18 | 天津天士力制药股份有限公司 | 一种速溶奶茶 |
CN101810263A (zh) * | 2009-12-16 | 2010-08-25 | 上海和兴源生物科技有限公司 | 复合生物糖 |
Non-Patent Citations (1)
Title |
---|
彭灿等: "红茶奶的研制", 《中国乳业》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106689417A (zh) * | 2016-08-29 | 2017-05-24 | 合肥康桥工贸有限公司 | 一种控糖中老年高钙奶粉 |
CN107114507A (zh) * | 2017-03-27 | 2017-09-01 | 柳州市雨滴餐饮管理有限公司 | 一种具有益生元组合物奶茶及其制备方法 |
CN113796442A (zh) * | 2021-09-24 | 2021-12-17 | 南通银琪生物科技有限公司 | 一种健康咖啡粉的配方及制作工艺 |
CN113796443A (zh) * | 2021-09-24 | 2021-12-17 | 南通银琪生物科技有限公司 | 一种咖啡饮片的配方及制作工艺 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5528718B2 (ja) | βグルカン組成物を用いた血糖値上昇抑制剤及びインスリン分泌促進剤 | |
US20030004215A1 (en) | Dietetic preparation and method for inhibiting intestinal carbohydrate absorption | |
CN103053903A (zh) | 一种具有降低食物血糖生成指数的复合功能糖 | |
CN104853779A (zh) | 包含环糊精的儿茶素生物利用度增强剂 | |
CN103976110B (zh) | 一种雪菊茶珍及其制备方法 | |
CN102613296A (zh) | 一种具有降糖降脂作用的奶茶 | |
CN102613369A (zh) | 具有降糖降脂作用的咖啡 | |
CN104758216B (zh) | 一种营养消炎含漱液及其制备方法 | |
Gutierrez et al. | Inhibitory effect of four types of tea on the in vitro digestion of starch | |
CN103054127B (zh) | 一种具有减肥功能的纤维素泡腾片 | |
Stoner | Food-based approach to cancer prevention | |
Choi et al. | Effects of Maclura tricuspidata (Carr.) Bur fruits and its phytophenolics on obesity‐related enzymes | |
CN102614203A (zh) | 具有α-葡萄糖苷酶抑制作用的低聚木糖组合物及其应用 | |
CN102885349A (zh) | 灵芝红枣浓浆 | |
CN104605430A (zh) | 直接利用山药制备的双歧因子异麦芽低聚糖功能饮料及其制备工艺 | |
CN102613455A (zh) | 具有胆固醇酯酶活性抑制作用的低聚木糖组合物及其应用 | |
CN102885352A (zh) | 香菇红枣浓浆 | |
CN102613342A (zh) | 具有降糖降脂作用的茶饮料 | |
CN101955874B (zh) | 一种苦杏酒的酿造方法 | |
CN106350387A (zh) | 一种虫草苹果肽发酵果酒的生产方法 | |
CN102894429A (zh) | 羊肚菌红枣浓浆 | |
CN102613456B (zh) | 具有脂肪酶活性抑制作用低聚木糖组合物及其应用 | |
CN111264877A (zh) | 一种药食同源高纤维功能性食品的制备方法 | |
CN110279050A (zh) | 一种清肠排毒的果蔬酵素饮料及其制备方法 | |
CN103045453B (zh) | 一种马齿苋醋及其制作方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: NIU ANLIN Free format text: FORMER OWNER: SUZHOU XIANKUO BIOLOGICAL TECHNOLOGY CO., LTD. Effective date: 20131118 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 215200 SUZHOU, JIANGSU PROVINCE TO: 215011 SUZHOU, JIANGSU PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20131118 Address after: 1102 box 215011, Suzhou City, Jiangsu Province Applicant after: Niu Anlin Address before: 215200, B building, building 206, Wujiang science and Technology Pioneer Park, 2358 Changan Road, Wujiang, Jiangsu, Suzhou Applicant before: Suzhou Xiankuo Biological Technology Co., Ltd. |
|
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120801 |